LISS SPEZIALE: Open Payments
NPI 1992239487 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 53 payments from 16 companies in 2025. Trend: 2023 $1,388 · 2024 $1,182 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $195 |
| Amgen Inc. | 15 | $193 |
| ABBVIE INC. | 12 | $184 |
| Madrigal Pharmaceuticals | 1 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $87 |
| Exact Sciences Corporation | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Eisai Inc. | 1 | $17 |
Products named: REXULTI, LINZESS, REZDIFFRA, JARDIANCE, OTEZLA, XIFAXAN, Cologuard Collection Kit, EVENITY.
Industry payments across NJ — which companies pay providers there.
